ISO 9001’s ongoing decline


Chris Paris has evaluated the 2016 ISO report on ISO 9001’s uptake.  Read his analysis here.

The ISO hasn’t bothered to correct misleading figures designed the inflate the standard’s popularity but it continues its secular trend of decline.

China and Italy have yet to see through it, but many other countries have begun to understand its worthlessness and are rejecting it.

You can understand why it’s so important for UKAS to gain gullible allies to continue the transfer of money from taxpayers to the inspection cartel.  ISO 15189 and 17025 continue to fool the medical and scientific professions and are growing as if they were compulsory.

It’s strange because even if they often lack the access to true price discovery and profit and loss accounts, these professionals have the statistical and investigatory knowledge to be able to prove the wastefulness that UKAS spreads.  Yet in their management and professional societies they push these practices without assessing their value.  They’d think more carefully if it were a new treatment for patients, yet ignore this ethical aspect as if they believe it is unlike other treatments and has no power to harm.  Why might that be?

UKAS hovers around in a safe zone where it’s learning to tell doctors what to do yet is distant enough to ensure it doesn’t get sued when things go wrong.

Things do go wrong and accreditation gives no clear protection.  Many major incidents occur despite (and perhaps because of) ISO accreditation.

Amtrak

Takata

Randox Testing Services

Accreditation won’t form part of the investigation.  UKAS is clean of any responsibility.  The solicitor will be writing to the hospital.

The UKAS Update newsletter tell us,

Working with NHS England to increase uptake of accreditation

NHS England recognises that quality improvement is critical to achieving world class, patient focused, safe, effective and efficient healthcare. Accreditation is one of the tools which provides assurance of standards, supports patient safety and ensures consistency of the quality of services and care that is delivered. UKAS continues to work with the Chief Scientific Officer of NHS England, Professor Sue Hill, and her team to raise awareness of the benefits of accreditation and support Trusts on their journey towards gaining accreditation for their full repertoire of scientific and diagnostic services.

Recently UKAS Senior Assessment Manager, Rebecca Gibbons, co-presented a webinar directed at Trust Lead Healthcare Scientists to provide background information about the different healthcare accreditation programmes that UKAS provides. UKAS’ Business Development Director, Lorraine Turner, was delighted to present to NHSE’s Leadership, Improvement and Advice (LIA) group. The LIA group is a consortium of senior healthcare science leaders from Trusts across England and is chaired by Fiona Carragher in her capacity as Deputy Chief Scientific Officer.

These presentations were aimed at encouraging Lead Scientists to utilise existing quality management expertise held within the Trusts to support the expansion of their scope of UKAS accreditation to cover other areas, and to highlight the similarities of the different accreditation programmes delivered by UKAS: Medical laboratories, Physiological Diagnostics (IQIPS), Diagnostic Imaging (ISAS) and Medical Physics and Clinical Engineering (MPACE).

In response to requests from Trusts and NHS England, UKAS is taking a more joined up approach to the assessment and accreditation of scientific and diagnostic services. This approach could result in improving the efficiency and effectiveness of the systems in place to provide assurance to patients, as well as reducing the overlap and resources required to undertake the UKAS assessments.

UKAS is also able to adopt a similar approach in other UK countries where it would be helpful, please speak to your Assessment Manager or the UKAS Team Leader for Healthcare, Le Tran (le.tran@ukas.com), for more information.

Expanding the scope for UKAS’s income generation in the name of quality.

Some hospitals are pushing ISO accreditation and Deming-based quality improvement at the same time.  They can’t see the contradiction.

They stand less chance of understanding it now that the ISO is trying to rewrite history and say they believed Deming in the first place.

Ask a patient if they notice an improvement because of accreditation.  Ask them if they’d pay their own money for it.

UKAS welcomes new Non-Executive Director

UKAS has recently welcomed Professor Adrian Newland to the UKAS Board as Non-Executive Director. Bringing a wealth of healthcare experience, Professor Newland is currently Professor of Haematology and Honorary Consultant at Barts Health NHS Trust in London and at the Queen Mary University of London. He is also Chair of the National Institute for Health and Care Excellence (NICE) Diagnostic Assessment Programme, co-Chair of the WHO Standing Advisory Group of experts in In vitro Diagnostic Devices and National Clinical Advisor in Pathology to NHS Improvement.

Throughout his career, Professor Newland has been involved in the establishment of standards and accreditation in the Healthcare sector. This began as a council member in the early 1990s when he was involved in the development of the Clinical Pathology Accreditation (CPA) scheme with Professor John Lilleyman for the Royal College of Pathologists. In subsequent years, he remained involved and was instrumental during his time as President of the Royal College of Pathologists (2005-2008) in helping forge closer links between CPA and UKAS. At that time, he also advised the President of the Royal College of Radiology, Dame Janet Husband, on the development of their radiology accreditation scheme, ISAS. Later in his role as secretary of the Academy of Medical Royal Colleges, he became their advisor on accreditation and was chair of the UKAS Healthcare Policy Advisory Forum.

On behalf of the Academy, Professor Newland also helped to develop the Healthcare Quality Improvement Partnership (HQIP) and was a member of its first board. He was also involved in the appointment of the executive team for the first physiological science accreditation scheme, IQIPS, for the Royal College of Physicians. Professor Newland was previously the President of the British Society for Haematology and the President of the International Society of Haematology (ISH) from 2014 – 2016.

Please join us in welcoming Professor Newland to UKAS.

Organisations that become members of UKAS become unable to criticise because they have been complicit in the errors.

Listen to the rest of the world that is rejecting ISO 9001 rather than the UKAS speaker at the dinner!

 

 

 

 

 

Advertisements
This entry was posted in Laboratory medicine, Management, NHS and tagged , , , , , , , , . Bookmark the permalink.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s